Belimumab after B cell depletion therapy in patients with systemic lupus erythematosus (BEAT Lupus) protocol: a prospective multicentre, double-blind, randomised, placebo-controlled, 52-week phase II clinical trial.
Alexis JonesPatrick MullerCaroline J DoreFelicia IkejiEmilia CaverlyKashfia ChowdhuryDavid Alan IsenbergCaroline GordonMichael R EhrensteinPublished in: BMJ open (2019)
ISRCTN47873; date assigned to the registry: 28 November 2016. The stage is pre-results.
Keyphrases
- placebo controlled
- phase ii
- double blind
- systemic lupus erythematosus
- clinical trial
- phase iii
- study protocol
- disease activity
- randomized controlled trial
- phase ii study
- open label
- heart rate
- mesenchymal stem cells
- radiation therapy
- cross sectional
- squamous cell carcinoma
- rectal cancer
- blood pressure
- replacement therapy